Torii, Sho
Jinnouchi, Hiroyuki
Sakamoto, Atsushi
Kutyna, Matthew
Cornelissen, Anne https://orcid.org/0000-0002-5452-4657
Kuntz, Salome
Guo, Liang
Mori, Hiroyoshi
Harari, Emanuel https://orcid.org/0000-0003-4454-5857
Paek, Ka Hyun
Fernandez, Raquel
Chahal, Diljon
Romero, Maria E.
Kolodgie, Frank D.
Gupta, Anuj
Virmani, Renu
Finn, Aloke V. https://orcid.org/0000-0003-0359-0184
Article History
Accepted: 25 June 2019
First Online: 25 July 2019
Competing interests
: S.T. receives research grants from SUNRISE lab. A.C. receives research grants from University Hospital RWTH Aachen. R.V. and A.V.F. have received institutional research support from 480 Biomedical, 4C Medical, 4Tech, Abbott, Accumedical, Amgen, Bard, Biosensors, Boston Scientific, Cardiac Implants, Celonova, Claret Medical, Concept Medical, Cook, CSI, DuNing, Edwards LifeSciences, Emboline, Endotronix, Envision Scientific, Gateway, Leducq Foundation Grant (R01 HL141425), Lifetech, Limflo, MedAlliance, Medtronic, Mercator, Merill, Microport Medical, Microvention, Mitraalign, Mitra assist, NAMSA, Nanova, Neovasc, NIPRO, Novogate, Occulotech, OrbusNeich Medical, Phenox, Profusa, Protembis, Qool, Recor, Senseonics, Shockwave, Sinomed, Spectranetics, Surmodics, Symic, Vesper, W.L. Gore and Xeltis. R.V. has received honoraria from Abbott Vascular, Biosensors, Boston Scientific, Celonova, Cook Medical, Cordis, CSI, Lutonix Bard, Medtronic, OrbusNeich Medical, CeloNova, SINO Medical Technology, ReCore, Spectranetics, Terumo Corporation and W. L. Gore. R.V. is a consultant for Abbott Vascular, Boston Scientific, Celonova, Cook Medical, Cordis, CSI, Edwards Lifescience, Lutonix Bard, Medtronic, OrbusNeich Medical, ReCore, Sinomededical Technology, Spectranetics, Surmodics, Terumo Corporation, W. L. Gore and Xeltis. A.V.F. has received honoraria from Abbott Vascular, Biosensors, Boston Scientific, Celonova, Cook Medical, CSI, Lutonix Bard, Sinomed and Terumo Corporation. A.V.F. is a consultant for Amgen, Abbott Vascular, Boston Scientific, Celonova, Cook Medical, Lutonix Bard and Sinomed. The other authors declare no competing interests.